MIKAYLA SEMENKO: Open Payments
NPI 1053071100 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 10 payments from 5 companies in 2025. Trend: 2023 $77 · 2024 $395 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $96 |
| ABBVIE INC. | 4 | $95 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $18 |
| SANOFI PASTEUR INC. | 1 | $16 |
Products named: KRYSTEXXA, VRAYLAR, Mirena, BEYFORTUS.
Industry payments across NV — which companies pay providers there.
